NDC 73309-165 - Olaparib
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-165
- Package NDCs from labels
- 73309-165-01, 73309-165-02
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2021-03-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Olaparib - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2021-03-24 | BULK INGREDIENT |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-165-01 | Olaparib | 10 g in 1 JAR | POWDER | 10 | 2 | |
| 73309-165-02 | Olaparib | 100 g in 1 JAR | POWDER | 100 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lynparza | OLAPARIB | AstraZeneca Pharmaceuticals LP | 741ff3e3-dc1a-45a6-84e5-2481b27131aa | 2025-07-10 | Warnings, Adverse reactions | WOH1JD9AR8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.